Browse by author
Lookup NU author(s): Professor Linda Sharp
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2021 UICC.When someone dies prematurely from cancer this represents a loss of productivity for society. This loss can be valued and provides a measure of the cancer burden. We estimated paid and unpaid productivity lost due to cancer-related premature mortality in 31 European countries in 2018. Lost productivity was estimated for all cancers combined and 23 cancer sites, overall, by region and country. Deaths aged 15 to 64 were abstracted from GLOBOCAN 2018. Unpaid time lost (housework, caring, volunteering) was derived from Eurostat. Paid and unpaid productivity losses were valued using the human capital approach. In total, 347,149 premature cancer deaths occurred (60% male). The total value of cancer-related lost productivity was €104.6 billion. Of this, €52.9 billion (50.6%) was due to lost paid work, and €51.7 billion (49.4%) to unpaid work. Females accounted for 36.7% of paid work costs but half (51.1%) of the unpaid work costs. Costs were highest in Western Europe (€52.0 billion). The most costly cancer was lung (€21.7 billion), followed by breast (€10.6 billion). The average loss per premature death was highest for Hodgkin's lymphoma (€506 345), melanoma (€450 694), brain cancer (€428 449) and leukaemia (€378 750). Cancer-related lost productivity costs are significant. Almost half are due to unpaid work losses, indicating the importance of considering both paid and unpaid labour in assessing the cancer economic burden. The high cost per premature death of some less common cancers illustrates the potential benefits that could accrue from investment in prevention and control of these cancers.
Author(s): Ortega-Ortega M, Hanly P, Pearce A, Soerjomataram I, Sharp L
Publication type: Article
Publication status: Published
Journal: International Journal of Cancer
Print publication date: 01/12/2022
Online publication date: 27/09/2021
Acceptance date: 06/09/2021
ISSN (print): 0020-7136
ISSN (electronic): 1097-0215
Publisher: John Wiley and Sons Inc
PubMed id: 34569617
Altmetrics provided by Altmetric